- Home
- PYXS
PYXS
Pyxis Oncology Inc.
as 11-15-2024 4:00pm EST
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 210.4M | IPO Year: | 2021 |
| Target Price: | $9.57 | AVG Volume (30 days): | 706.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.06 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.35 - $6.85 | Next Earning Date: | 11-12-2024 |
| Revenue: | $16,146,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Pyxis Oncology Inc. News
PYXS Breaking Stock News: Dive into PYXS Ticker-Specific Updates for Smart Investing
GlobeNewswire
5 days ago
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024
GlobeNewswire
6 days ago
Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201
GlobeNewswire
3 months ago
Pyxis Oncology to Participate in Two Upcoming Investor Conferences
GlobeNewswire
3 months ago
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024
GlobeNewswire
4 months ago
Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference
GlobeNewswire
5 months ago
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Simply Wall St.
5 months ago
Institutional owners may ignore Pyxis Oncology, Inc.'s (NASDAQ:PYXS) recent US$25m market cap decline as longer-term profits stay in the green
Yahoo Finance Video
5 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
Compare PYXS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PYXS Pyxis Oncology Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.